Drug Shortage Report for NALCROM
Report ID | 134957 |
Drug Identification Number | 00500895 |
Brand name | NALCROM |
Common or Proper name | Nalcrom |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | CROMOLYN SODIUM |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | A07EB |
ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-03-31 |
Actual start date | |
Estimated end date | 2021-05-21 |
Actual end date | 2021-05-21 |
Shortage status | Resolved |
Updated date | 2021-05-22 |
Company comments | The Nalcrom shortage was due to a manufacturing delay. The extension is linked to receiving added information related to a GMP requirement. Sanofi has initiated a product allocation based on previous order history with its distributors. Availability dates at individual distributor warehouses may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2021-05-22 | English | Compare |
v13 | 2021-05-21 | French | Compare |
v12 | 2021-05-21 | English | Compare |
v11 | 2021-04-30 | French | Compare |
v10 | 2021-04-30 | English | Compare |
v9 | 2021-04-23 | French | Compare |
v8 | 2021-04-23 | English | Compare |
v7 | 2021-04-01 | English | Compare |
v6 | 2021-03-02 | French | Compare |
v5 | 2021-03-02 | English | Compare |
v4 | 2021-03-02 | French | Compare |
v3 | 2021-03-02 | English | Compare |
v2 | 2021-03-02 | English | Compare |
v1 | 2021-03-02 | English | Compare |
Showing 1 to 14 of 14